Neuromodulatory Effects of Leukotriene receptor antagonists: A comprehensive review.
LTRAs
Neurodegeneration
Neuroinflammation
Neuroprotection
Synaptic plasticity
Journal
European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354
Informations de publication
Date de publication:
21 Jun 2024
21 Jun 2024
Historique:
received:
19
02
2024
revised:
09
06
2024
accepted:
16
06
2024
medline:
24
6
2024
pubmed:
24
6
2024
entrez:
23
6
2024
Statut:
aheadofprint
Résumé
Cysteinyl leukotrienes (CysLTs) are central to the pathophysiology of asthma and various inflammatory disorders. Leukotriene receptor antagonists (LTRAs) effectively treat respiratory conditions by targeting cysteinyl leukotriene receptors, CysLT
Identifiants
pubmed: 38909933
pii: S0014-2999(24)00443-6
doi: 10.1016/j.ejphar.2024.176755
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
176755Informations de copyright
Copyright © 2024. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest We confirm that the paper has been seen and reviewed by co-authors, approved the submission to the journal. We confirm that there are no conflicts of interest in this paper.